Dual Actions of Ketorolac in Metastatic Ovarian Cancer

Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor

(2019) Allison Gartung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Critical Questions in Ovarian Cancer Research and Treatment: Report of an American Association for Cancer Research Special Conference

(2019) Robert C. Bast et al.   CANCER

Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases

(2019) Dipak Panigrahy et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting Rac and Cdc42 GTPases in Cancer

(2018) María del Mar Maldonado et al.   CANCER RESEARCH

Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time?

(2018) Paul DiSilvestro et al.   CANCER TREATMENT REVIEWS

Metastatic gynecologic malignancies: advances in treatment and management

(2018) John K. Chan et al.   CLINICAL & EXPERIMENTAL METASTASIS

Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics

(2018) G.A. Cardama et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Non-aspirin NSAID use and ovarian cancer mortality

(2018) Freija Verdoodt et al.   GYNECOLOGIC ONCOLOGY

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium

(2018) Britton Trabert et al.   JNCI-Journal of the National Cancer Institute

Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient’s Body Mass Index

(2018) Christine Desmedt et al.   JNCI-Journal of the National Cancer Institute

Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence

(2018) Ryungsa Kim   Journal of Translational Medicine

Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study

(2018) Melissa A Merritt et al.   LANCET ONCOLOGY

Does aspirin have a role in management of ovarian cancer?

(2018) Penelope M Webb   LANCET ONCOLOGY

Paving the Rho in cancer metastasis: Rho GTPases and beyond

(2018) Sepp Jansen et al.   PHARMACOLOGY & THERAPEUTICS

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

(2018) Madalene Earp et al.   PLoS One

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors

(2018) Alicia Beeghly-Fadiel et al.   Journal of Ovarian Research

Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis

(2018) Shu Lou et al.   Journal of Cancer

Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium

(2018) Britton Trabert et al.   JNCI-Journal of the National Cancer Institute

Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient’s Body Mass Index

(2018) Christine Desmedt et al.   JNCI-Journal of the National Cancer Institute

Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial

(2018) Michael A. Ulm et al.   GYNECOLOGIC ONCOLOGY

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

(2018) Sudha Savant et al.   Cancers

Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase

(2018) Laurie Hudson et al.   Cancers

Targeting the Microenvironment in High Grade Serous Ovarian Cancer

(2018) Nkechiyere Nwani et al.   Cancers

Activated Rho GTPases in Cancer—The Beginning of a New Paradigm

(2018) Pontus Aspenström   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

(2018) Kathleen Moore et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic value of serum IL-8 and IL-10 in patients with ovarian cancer undergoing chemotherapy

(2018) Lixia Zhang et al.   Oncology Letters

Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies

(2018) Mollie E. Barnard et al.   JAMA Oncology

1,2,3-Triazolyl ester of Ketorolac: A “Click Chemistry”-based highly potent PAK1-blocking cancer-killer

(2017) Binh Cao Quan Nguyen et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Rho GTPases as therapeutic targets in cancer (Review)

(2017) G.A. Cardama et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells

(2017) Guomei Zhou et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Rho GTPase signaling complexes in cell migration and invasion

(2017) Campbell D. Lawson et al.   JOURNAL OF CELL BIOLOGY

Preventive therapy for cancer

(2017) Jack Cuzick   LANCET ONCOLOGY

Influence of aspirin and non-aspirin NSAID use on ovarian and endometrial cancer: Summary of epidemiologic evidence of cancer risk and prognosis

(2017) F. Verdoodt et al.   MATURITAS

Perioperative events influence cancer recurrence risk after surgery

(2017) Jonathan G. Hiller et al.   Nature Reviews Clinical Oncology

Ovarian cancer stem cells more questions than answers

(2017) Petronella Beatrix Ottevanger   SEMINARS IN CANCER BIOLOGY

Analgesic medication use and risk of epithelial ovarian cancer in African American women

(2016) Lauren C Peres et al.   BRITISH JOURNAL OF CANCER

The role of aspirin in colorectal cancer chemoprevention

(2016) Gurpreet Singh Ranger   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis

(2016) Dongyu Zhang et al.   GYNECOLOGIC ONCOLOGY

Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies

(2016) Freija Verdoodt et al.   GYNECOLOGIC ONCOLOGY

Propranolol Attenuates Surgical Stress–Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy

(2016) Lei Zhou et al.   JOURNAL OF IMMUNOLOGY

Can advanced-stage ovarian cancer be cured?

(2016) Steven Narod   Nature Reviews Clinical Oncology

Epithelial–mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways

(2016) D Fang et al.   ONCOGENE

Rho GTPases: Anti- or pro-neoplastic targets?

(2016) I Zandvakili et al.   ONCOGENE

Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis

(2016) Parambir S Dulai et al.   BMJ-British Medical Journal

Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis

(2016) Parambir S Dulai et al.   BMJ-British Medical Journal

Structural Mechanisms and Drug Discovery Prospects of Rho GTPases

(2016) Cameron Smithers et al.   Cells

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis

(2015) Tsz-Lun Yeung et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Thalidomide-induced teratogenesis: History and mechanisms

(2015) Neil Vargesson   BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival

(2015) Christina M. Nagle et al.   Cancer Epidemiology

A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients

(2015) Y. Guo et al.   CLINICAL CANCER RESEARCH

Rho GTPase signalling in cell migration

(2015) Anne J Ridley   CURRENT OPINION IN CELL BIOLOGY

Approaches of targeting Rho GTPases in cancer drug discovery

(2015) Yuan Lin et al.   Expert Opinion on Drug Discovery

Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives

(2015) K. Matsumoto et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome

(2015) Ruobing Leng et al.   MEDICAL ONCOLOGY

R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis

(2015) Y. Guo et al.   MOLECULAR CANCER THERAPEUTICS

Exploiting the critical perioperative period to improve long-term cancer outcomes

(2015) Maya Horowitz et al.   Nature Reviews Clinical Oncology

Inflammation and cancer: advances and new agents

(2015) Shanthini M. Crusz et al.   Nature Reviews Clinical Oncology

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer

(2015) Andrew J. Wilson et al.   Oncotarget

Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study

(2015) Jae Eun Choi et al.   Cancer Medicine

Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases

(2015) Tudor I. Oprea et al.   PLoS One

Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?

(2014) Álvaro Henrique Ingles Garces et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice

(2014) K. Schmitz et al.   EMBO Molecular Medicine

Multimodal pain control is associated with reduced hospital stay following open abdominal hysterectomy

(2014) Joseph T. Santoso et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

(2013) Patrice Forget et al.   ANNALS OF SURGICAL ONCOLOGY

Pathview: an R/Bioconductor package for pathway-based data integration and visualization

(2013) Weijun Luo et al.   BIOINFORMATICS

Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science

(2013) Ibrahim Halil Sahin et al.   CANCER LETTERS

The long and winding road of non steroidal antinflammatory drugs and paracetamol in cancer pain management: A critical review

(2013) Sebastiano Mercadante et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review

(2013) Michael Retsky et al.   CURRENT MEDICINAL CHEMISTRY

Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe

(2013) Lin Hong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of Aspirin in Cancer Prevention

(2013) Mangesh A. Thorat et al.   Current Oncology Reports

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

(2012) A. K. L. Reyners et al.   ANNALS OF ONCOLOGY

NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup

(2012) Michael Retsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis?

(2012) Á Heaney et al.   BRITISH JOURNAL OF ANAESTHESIA

Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian cancer

(2012) Xiaojian Ni et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review

(2012) Megan A. Murphy et al.   CANCER CAUSES & CONTROL

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review

(2011) Jessica C. Wilson et al.   CANCER CAUSES & CONTROL

Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?

(2011) Patrice Forget et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro

(2011) James K. Liu et al.   JOURNAL OF NEURO-ONCOLOGY

Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis

(2010) Patrice Forget et al.   ANESTHESIA AND ANALGESIA

Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen

(2010) Kelsey C. Duggan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

GAGE: generally applicable gene set enrichment for pathway analysis

(2009) Weijun Luo et al.   BMC BIOINFORMATICS

Aspirin Use and Survival After Diagnosis of Colorectal Cancer

(2009) Andrew T. Chan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Chiral Toxicology: It's the Same Thing…Only Different

(2009) Silas W. Smith   TOXICOLOGICAL SCIENCES

The effects of surgery on tumor growth: a century of investigations

(2008) R. Demicheli et al.   ANNALS OF ONCOLOGY

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

(2008) Da Wei Huang et al.   NUCLEIC ACIDS RESEARCH

The prognostic significance of COX-2 and survivin expression in ovarian cancer

(2008) Pauline Athanassiadou et al.   PATHOLOGY RESEARCH AND PRACTICE